Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease

被引:58
作者
Lv, Zhanyun [1 ,2 ]
Jiang, Hong [1 ,2 ]
Xu, Huamin [1 ,2 ]
Song, Ning [1 ,2 ]
Xie, Junxia [1 ,2 ]
机构
[1] Qingdao Univ, Coll Med, Dept Physiol, State Key Disciplines Physiol Incubat, Qingdao 266071, Peoples R China
[2] Qingdao Univ, Coll Med, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Dept Physiol, Qingdao 266071, Peoples R China
关键词
Divalent metal transporter 1; Ferroportin; 1; Iron; A-synuclein; Parkinson's disease; METAL TRANSPORTER 1; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; IN-VITRO; INCLUSION-BODIES; OXIDATIVE STRESS; UP-REGULATION; MOUSE MODEL; CELL-DEATH; MPTP;
D O I
10.1007/s00702-010-0434-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The staging of Lewy-related pathology in sporadic Parkinson's disease (PD) reveals that many brain nuclei are affected in PD during different stages, except the ventral tegmental area (VTA), which is close related to the substantia nigra (SN) and enriched in dopamine (DA) neurons. Why DA neurons are selectively degenerated in the SN of PD is far from known. In the present study, we observed that the number of tyrosine hydroxylase immunoreactive neurons decreased and iron-staining positive cells increased in the SN, but not in the VTA, in the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated PD mice. Increased expression of divalent metal transporter 1 and decreased expression of ferroportin 1 might associate with this increased nigral iron levels. Lipofuscin granular aggregations and upregulation of alpha-synuclein (alpha-synuclein) were also observed only in the SN. These results suggest that increased iron levels associate with the selective degeneration of DA neurons in the SN. The intracellular regulation mechanisms for the iron transporters may be different in the SN and VTA under the same conditions. Moreover, the lipofuscin granular aggregations and upregulation of alpha-synuclein were also involved in the selective degeneration of dopaminergic neurons in the SN.
引用
收藏
页码:361 / 369
页数:9
相关论文
共 50 条
[41]   Reproducible detection of nigral iron deposition in 2 Parkinson's disease cohorts [J].
Langley, Jason ;
He, Naying ;
Huddleston, Daniel E. ;
Chen, Shengdi ;
Yan, Fuhua ;
Crosson, Bruce ;
Factor, Stewart ;
Hu, Xiaoping .
MOVEMENT DISORDERS, 2019, 34 (03) :416-420
[42]   Iron accumulation in Parkinson's disease [J].
Mochizuki, Hideki ;
Yasuda, Toru .
JOURNAL OF NEURAL TRANSMISSION, 2012, 119 (12) :1511-1514
[43]   Paraquat as an Environmental Risk Factor in Parkinson's Disease Accelerates Age-Related Degeneration Via Rapid Influx of Extracellular Zn2+ into Nigral Dopaminergic Neurons [J].
Tamano, Haruna ;
Nishio, Ryusuke ;
Morioka, Hiroki ;
Furuhata, Ryo ;
Komata, Yuuma ;
Takeda, Atsushi .
MOLECULAR NEUROBIOLOGY, 2019, 56 (11) :7789-7799
[44]   Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators [J].
Weinreb, Orly ;
Mandel, Silvia ;
Youdim, Moussa B. H. ;
Amit, Tamar .
FREE RADICAL BIOLOGY AND MEDICINE, 2013, 62 :52-64
[45]   NOSH-aspirin (NBS-1120) attenuates motor defects and dopaminergic neuron degeneration in a rat model of Parkinson's disease [J].
Firouzan, Bita ;
Ghasemi, Rasoul ;
Tetteh, Michael T. ;
Matson, John B. ;
Kashfi, Khosrow .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 1002
[46]   Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update [J].
Brichta, Lars ;
Greengard, Paul .
FRONTIERS IN NEUROANATOMY, 2014, 8
[47]   Dopaminergic Neuroprotection with Atremorine in Parkinson's Disease [J].
Carrera, Ivan ;
Fernandez-Novoa, Lucia ;
Sampedro, Carolina ;
Tarasov, Vadim V. ;
Aliev, Gjumrakch ;
Cacabelos, Ramon .
CURRENT MEDICINAL CHEMISTRY, 2018, 25 (39) :5372-5388
[48]   Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise Implications for iron-related dopaminergic neuron degeneration [J].
Zhou, Zhi Dong ;
Lan, Yu Hong ;
Tan, Eng King ;
Lim, Tit Meng .
FREE RADICAL BIOLOGY AND MEDICINE, 2010, 49 (12) :1856-1871
[49]   Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson's disease [J].
Duce, James A. ;
Wong, Bruce X. ;
Durham, Hannah ;
Devedjian, Jean-Christophe ;
Smith, David P. ;
Devos, David .
MOLECULAR NEURODEGENERATION, 2017, 12
[50]   Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease [J].
Anandhan, Annadurai ;
Tamilselvam, Kuppusamy ;
Radhiga, Thangaiyan ;
Rao, Shalinee ;
Essa, Musthafa Mohamed ;
Manivasagam, Thamilarasan .
BRAIN RESEARCH, 2012, 1433 :104-113